Cormorant Asset Management’s Attovia Therapeutics ATTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$30.7M Buy
+1,788,815
New +$37.7M 2.06% 15

Other funds holding ATTO

Cormorant Asset Management's ATTO Position: Q3 2026 in Review

Cormorant Asset Management opened a new position in Attovia Therapeutics (ATTO) in Q3 2026: 1,788,815 shares worth $30.7M. The stake represents 2.06% of the portfolio and ranks #15 among its holdings.

57 funds tracked by Wall St. Rank hold ATTO as of Q3 2026.

  • Cormorant Asset Management held 1,788,815 shares of Attovia Therapeutics worth $30.7M as of Q3 2026.
  • Attovia Therapeutics was a new Cormorant Asset Management position in Q3 2026.
  • Attovia Therapeutics made up 2.06% of Cormorant Asset Management's portfolio in Q3 2026, its #15 holding.
  • 57 funds tracked by Wall St. Rank held Attovia Therapeutics as of Q3 2026.

Based on Cormorant Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.